122 related articles for article (PubMed ID: 26169945)
1. Icariin reduces α-synuclein over-expression by promoting α-synuclein degradation.
Zhang L; Shen C; Chu J; Liu Y; Li Y; Zhang L; Li L
Age (Dordr); 2015 Aug; 37(4):9811. PubMed ID: 26169945
[TBL] [Abstract][Full Text] [Related]
2. Icariin Inhibits Overexpression and Aggregation of α-Synuclein in A53T α-Synuclein Transgenic Mice by Regulating Parkin and PLK2.
Ma D; Shen C; Zhang X; Zhang L; Li L
J Integr Neurosci; 2023 Nov; 22(6):166. PubMed ID: 38176950
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydroxystilbene glucoside antagonizes age-related α-synuclein overexpression in the hippocampus of APP transgenic mouse model of Alzheimer's disease.
Zhang L; Yu S; Zhang R; Xing Y; Li Y; Li L
Restor Neurol Neurosci; 2013; 31(1):41-52. PubMed ID: 23160059
[TBL] [Abstract][Full Text] [Related]
4. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ubiquitin-proteasome system in icariin-induced cardiomyocyte differentiation of embryonic stem cells using two-dimensional gel electrophoresis.
Zhu DY; Cui R; Zhang YY; Li H; Zhou LM; Lou YJ
J Cell Biochem; 2011 Nov; 112(11):3343-53. PubMed ID: 21751238
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of UCHL1 modulation on alpha-synuclein in PD-like models of alpha-synucleinopathy.
Cartier AE; Ubhi K; Spencer B; Vazquez-Roque RA; Kosberg KA; Fourgeaud L; Kanayson P; Patrick C; Rockenstein E; Patrick GN; Masliah E
PLoS One; 2012; 7(4):e34713. PubMed ID: 22514658
[TBL] [Abstract][Full Text] [Related]
7. Effects of titanium dioxide nanoparticles on α-synuclein aggregation and the ubiquitin-proteasome system in dopaminergic neurons.
Wu J; Xie H
Artif Cells Nanomed Biotechnol; 2016; 44(2):690-4. PubMed ID: 25386730
[TBL] [Abstract][Full Text] [Related]
8. [Impacts of electroacupuncture on ubiquitin-proteasome system in rats with Parkinson's disease].
Wang YC; He F; Ma J; Zhou D; Liang Y; Gong YX
Zhongguo Zhen Jiu; 2013 Aug; 33(8):725-9. PubMed ID: 24195216
[TBL] [Abstract][Full Text] [Related]
9. Membrane-associated farnesylated UCH-L1 promotes alpha-synuclein neurotoxicity and is a therapeutic target for Parkinson's disease.
Liu Z; Meray RK; Grammatopoulos TN; Fredenburg RA; Cookson MR; Liu Y; Logan T; Lansbury PT
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4635-40. PubMed ID: 19261853
[TBL] [Abstract][Full Text] [Related]
10. Aberrant interaction between Parkinson disease-associated mutant UCH-L1 and the lysosomal receptor for chaperone-mediated autophagy.
Kabuta T; Furuta A; Aoki S; Furuta K; Wada K
J Biol Chem; 2008 Aug; 283(35):23731-8. PubMed ID: 18550537
[TBL] [Abstract][Full Text] [Related]
11. Expression in the mammalian retina of parkin and UCH-L1, two components of the ubiquitin-proteasome system.
Esteve-Rudd J; Campello L; Herrero MT; Cuenca N; Martín-Nieto J
Brain Res; 2010 Sep; 1352():70-82. PubMed ID: 20638372
[TBL] [Abstract][Full Text] [Related]
12. Parkin-mediated K63-polyubiquitination targets ubiquitin C-terminal hydrolase L1 for degradation by the autophagy-lysosome system.
McKeon JE; Sha D; Li L; Chin LS
Cell Mol Life Sci; 2015 May; 72(9):1811-24. PubMed ID: 25403879
[TBL] [Abstract][Full Text] [Related]
13. Role of autophagy and proteasome degradation pathways in apoptosis of PC12 cells overexpressing human alpha-synuclein.
Yang F; Yang YP; Mao CJ; Cao BY; Cai ZL; Shi JJ; Huang JZ; Zhang P; Liu CF
Neurosci Lett; 2009 May; 454(3):203-8. PubMed ID: 19429084
[TBL] [Abstract][Full Text] [Related]
14. Analysis of alpha-synuclein, parkin, tau, and UCH-L1 in a Japanese family with autosomal dominant parkinsonism.
Hasegawa K; Funayama M; Matsuura N; Furusawa H; Sakai F; Kowa H; Obata F
Eur Neurol; 2001; 46(1):20-4. PubMed ID: 11455179
[TBL] [Abstract][Full Text] [Related]
15. Excess α-synuclein worsens disease in mice lacking ubiquitin carboxy-terminal hydrolase L1.
Shimshek DR; Schweizer T; Schmid P; van der Putten PH
Sci Rep; 2012; 2():262. PubMed ID: 22355774
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of ATP-induced currents due to the activation of P2X receptors by ubiquitin carboxy-terminal hydrolase L1.
Manago Y; Kanahori Y; Shimada A; Sato A; Amano T; Sato-Sano Y; Setsuie R; Sakurai M; Aoki S; Wang YL; Osaka H; Wada K; Noda M
J Neurochem; 2005 Mar; 92(5):1061-72. PubMed ID: 15715657
[TBL] [Abstract][Full Text] [Related]
17. Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains.
Doss-Pepe EW; Chen L; Madura K
J Biol Chem; 2005 Apr; 280(17):16619-24. PubMed ID: 15718234
[TBL] [Abstract][Full Text] [Related]
18. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
19. Silica nanoparticles induce alpha-synuclein induction and aggregation in PC12-cells.
Xie H; Wu J
Chem Biol Interact; 2016 Oct; 258():197-204. PubMed ID: 27613482
[TBL] [Abstract][Full Text] [Related]
20. A53T α-synuclein induces neurogenesis impairment and cognitive dysfunction in line M83 transgenic mice and reduces the proliferation of embryonic neural stem cells.
Zhang Y; Wu Q; Ren Y; Zhang Y; Feng L
Brain Res Bull; 2022 May; 182():118-129. PubMed ID: 35182691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
